"Designing Growth Strategies is in our DNA"

Infectious Disease Molecular Diagnostics Market Size, Share and Global Trend By Technology (Mass Spectroscopy, Capillary Electrophoresis, Next Generation Sequencing, Chips & Microarrays, In-Situ Hybridization), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV) Infection, Human Papillomavirus (HPV) Infection), By End User (Hospitals & Clinics, Diagnostic Centres, Research Institutes) and Geography Forecast till 2026

Region : Global | Report ID: FBI101146 | Status : Ongoing

 

KEY MARKET INSIGHTS

Infectious diseases refer to the diseases caused by various organisms such as bacteria, virus, parasites, and fungi and can be passed from individual to individual or even from animal to individuals such as rabies. Early and accurate detection of infectious diseases is of utmost importance as it spread from one person to another. Molecular diagnostics serve as an effective tool for the detection of HIV, HPV, and other infectious diseases.


There is active support from the government to tackle the rising prevalence and economic burden of infectious diseases. Also, strategic collaboration and the launch of new molecular diagnostic platforms or instruments have surged the market. Awareness and shift towards personalized medicines and preventive care are expected to further enhance the demand for infectious disease diagnostic techniques.


To gain extensive insights into the market, Request for Customization


The global infectious disease molecular diagnostics market is anticipated to grow owing to the increasing prevalence of infectious diseases, rising awareness regarding prevention and early diagnosis of sexually transmitted diseases, and active government support. The World Health Organization (WHO) estimated that there were approximately 36.9 million individuals diagnosed with HIV at the end of 2017, with a new 1.8 million people diagnosed in 2017 globally. These trends, combined with the other factors, are expected to drive the growth in the infectious disease molecular diagnostics market growth during the forecast duration.


However, lack of skilled labor in developing countries, high installation and infrastructure cost can hinder the growth in the global infectious disease molecular diagnostics market. 


Key Players Covered


Some of the major companies that are present in the global infectious disease molecular diagnostics market are Abbott, Becton, Dickinson and Company, QIAGEN, Cepheid, bioMérieux SA, Hologic Inc., Myriad Genetics and Thermo Fisher Scientific.


SEGMENTATION


























SEGMENTATION


DETAILS

By Technology



· Mass Spectroscopy


· Capillary Electrophoresis


· Next Generation Sequencing (NGS)


· Chips & Microarrays


· In-Situ Hybridization (ISH)


· Others



By Disease Indication



· Hepatitis


· Human Immunodeficiency Virus (HIV) Infection


· Human Papillomavirus (HPV) Infection


· Others



By End User



· Hospitals & Clinics


· Diagnostic Centres


· Research Institutes


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


Among the segmentation, Next Generation Sequencing (NGS) segment is projected to hold a considerable share of the global infectious disease molecular diagnostics market in the forecast period due to increased preference for next-generation sequencing technology, new product launch, increased research and cost-effectiveness.


Key Insights



  • Prevalence of infectious diseases

  • The regulatory scenario for key countries

  • Reimbursement scenario for key countries

  • New product launch

  • Technological advancements in molecular diagnosis

  • Recent industry developments such as partnerships, mergers, and acquisitions


Regional Analysis


North America is estimated to dominate the global infectious disease molecular diagnostics market over the forecast period due to the increasing prevalence of infectious diseases such as HIV and respiratory diseases, established healthcare system, and increased R&D investment. Asia Pacific is projected to report significant growth in the global infectious disease molecular diagnostics market due to active government support, improving access to the advanced diagnostic facility and rapid adoption of preventive care.


Key Industry Developments



  • In August 2018, Bruker Corporation announced the acquisition of Hain Lifescience GmbH, an infectious disease molecular diagnostic company, to expand their footprint in molecular diagnostics.

  • In January 2019, Qiagen announced the launch of QIAscreen HPV PCR Test, an in-vitro molecular diagnostics test for the detection of human papillomavirus in Europe.

  • In February 2018, BD received per-marketing approval from the FDA for the BD Onclarity HPV assay to be performed on molecular platform using BD Viper LT system to identify human papillomavirus (HPV) genotypes.


Infectious Disease Molecular Diagnostics Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Healthcare Clients

DUPONT
Bio-Rad
DAEWOONG
baxter
Abbott

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X